Inovio Pharmaceuticals Begins Phase 1 Human Testing Of Its COVID-19 Vaccine
FDA Removes Clinical Hold On Inovio Pharma's VGX-3100, Its First Drug To Enter A Pivotal Study
Inovio Shares Off 4% After EORTC Trial Enrollment Will Not Go Through
EXCLUSIVE: Inovio Plans On Producing Zika Vaccine By Q3 2016, Ready For Phase 1 Study By Q4